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Abstract
Background: Genomic imprinting is an epigenetic chromosomal modification in the gametes or
zygotes that results in a non-random monoallelic expression of specific autosomal genes depending
upon their parent of origin. Approximately 44 human genes have been reported to be imprinted.
A majority of them are clustered, including some on chromosome segment 11p15.5. We report
here the imprinting status of the SLC22A1LS gene from the human chromosome segment 11p15.5
Results:  In order to test for allele specific expression patterns, PCR primer sets from the
SLC22A1LS gene were used to look for heterozygosity in DNA samples from 17 spontaneous
abortuses using PCR-SSCP and DNA sequence analyses. cDNA samples from different tissues of
spontaneous abortuses showing heterozygosity were subjected to PCR-SSCP analysis to determine
the allele specific expression pattern. PCR-SSCP analysis revealed heterozygosity in two of the 17
abortuses examined. DNA sequence analysis showed that the heterozygosity is caused by a G>A
change at nucleotide position 473 (c.473G>A) in exon 4 of the SLC22A1LS gene. PCR-SSCP analysis
suggested that this gene is paternally imprinted in five fetal tissues examined.
Conclusions: This study reports the imprinting status of the SLC22A1LS gene for the first time.
The results suggest imprinting of the paternal allele of this gene in five fetal tissues: brain, liver,
placenta, kidneys and lungs.
Background
Imprinted genes are specific autosomal genes that show a
non-random monoallelic expression depending upon
their parent of origin [1,2]. It is estimated that the human
genome contains 100–300 imprinted genes [3,4]. A cata-
logue of the imprinted genes maintained at the University
of Otago, New Zealand [5] lists approximately 44 human
genes. In addition, the catalogue lists six more genes
whose imprinting status is disputable.
Studies on uniparental disomies (UPDs) have identified
five imprinted segments in the human genome including
the chromosome segment 11p15.5 [6,7]. The imprinted
segment on chromosome 11p15.5 is involved in the
pathogenesis of Beckwith-Wiedemann syndrome. It is ~1
Mb in size and harbors a total of 21 genes [8]. Of these, 11
genes are known to be imprinted, seven genes show bial-
lelic expression and the imprinting status of the remain-
ing three genes including the SLC22A1LS is unknown. The
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Genomic imprinting of the SLC22A1LS gene Figure 1
Genomic imprinting of the SLC22A1LS gene: A) diagrammatic representation of SLC22A1L and SLC22A1LS genes; positions of 
the primer set 22F-22R are marked by arrow heads. B) PCR-SSCP analysis of genomic DNA samples from 17 abortuses (no. 2 
to no. 18) with the primer set 22F-22R; two abortuses, no. 2 and no. 9 are heterozygous for a nucleotide change. C) Direct 
sequence analysis of the PCR product with the primer 22F from the abortus no. 2 showing a G>A change at nucleotide posi-
tion 473 (c.473G>A) marked by an arrow. D) PCR-SSCP analysis of genomic DNA samples from a control individual (N), abor-
tus no. 2 (2), mother of the abortus no. 2 (M), and cDNA samples from lungs (L), liver (Li), brain (B), kidneys (K) and placenta 
(P). Note, only one allele 473G is expressed in five tissues analyzed. Since the abortus is heterozygous and the mother is 
homozygous, the imprinted allele 476A in the abortus should have come from its father. E) PCR-SSCP analysis of genomic 
DNA samples from a control individual (N), abortus no. 9 (9), mother of the abortus no. 9 (M), and cDNA samples from lungs 
(L), liver (Li), brain (B), and kidneys (K). Note, only one allele 473G is expressed in all four tissues analyzed, corroborating the 
finding from the abortus no. 2. Since both the mother and the abortus are heterozygous, it is not possible to determine the 
parental origin of the expressed allele.BMC Genetics 2004, 5 http://www.biomedcentral.com/1471-2156/5/13
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SLC22A1LS gene contains four exons and encodes for a
transcript of 1,342 bp length [9,10]. It is expressed in the
liver, gastrointestinal tract, kidneys and placenta [10]. It
codes for a putative protein of 253 amino acids length
with unknown function. The SLC22A1LS protein does not
show sequence homology to any known proteins [9,10].
The SLC22A1LS gene has no counterpart in the mouse
genome [9], perhaps reflecting an example of the rapid
evolution of human genomic sequences. The DNA
sequence of this gene partially overlaps with that of
another gene, SLC22A1L (BWR1A), which has been
shown to be paternally imprinted [9,10]. These two genes
are transcribed in opposite directions (Fig. 1A). We report
here a study on the imprinted status of the SLC22A1LS
(BWR1B) gene.
Results and discussion
PCR-SSCP analysis performed on genomic DNA samples
from 17 abortuses showed heterozygosity in abortus no. 2
and no. 9 only with the primer set 22F/22R (Fig. 1B). The
other two primer sets did not show heterozygosity in 17
abortuses (data not shown). DNA sequence analysis
revealed that the heterozygosity in these abortuses was
due to a G>A substitution at nucleotide position 473
(c.473G>A) (Fig. 1C). We have designated the two alleles
as 473G and 473A, the wild type being 473G (Fig. 1C).
In order to determine if both or only one allele of this
gene is expressed, PCR-SSCP analysis was performed
using cDNA samples from different tissues of abortus nos.
2 and 9. The analysis showed expression of the allele
473G only in five tissues from abortus no. 2 (Fig. 1D)
indicating that this gene was imprinted. Since the mother
was homozygous for the expressed allele 473G and the
abortus was heterozygous, the imprinted allele in this
abortus must be derived from its father. This suggested
imprinting of the paternal allele of the SLC22A1LS gene.
The monoallelic expression of this gene was further con-
firmed in brain, lungs, liver and kidneys from another het-
erozygous abortus, no. 9 (Fig. 1E).
Based on their opposite orientation and knowing that
SLC22A1L is paternally imprinted (maternally expressed),
it was hypothesized that the SLC22A1LS gene, which over-
laps with SLC22A1L, should be maternally imprinted [9].
However, our results suggested that on the contrary,
SLC22A1LS is paternally imprinted, just as is the case with
its sense partner SLC22A1L. This pattern is similar to that
observed in case of IGF2 and its antisense transcript IGF2-
AS, both of which express the same (paternal) allele [11].
These two examples suggest that expression of sense and
antisense transcripts of a gene pair may be under the same
imprinting or genetic control. It is also possible that the
transcript of one gene could be regulating the transcrip-
tion of its partner. The 'sense partner' of the SLC22A1LS
gene, SLC22A1L, has been found to be mutated in a breast
and rhabdomyosarcoma cell lines [10]. Since patients
with Beckwith-Wiedemann syndrome are known to be
prone to a variety of tumors, it is possible that these genes
have a role in the pathogenesis of this syndrome and in
the etiology of other tumors including Wilm's tumor,
although this possibility remains to be investigated.
Conclusions
We report for the first time the imprinting status of the
SLC22A1LS gene located in human chromosome segment
11p15.5. The results suggest imprinting of the paternal
allele of this gene in different fetal tissues.
Methods
Sample collection
A total of 17 spontaneous abortuses were ascertained over
a period of three years in the Department of Gynecology
and Obstretics, Kempegowda Institute of Medical Sci-
ences, Bangalore. Following abortion, different fetal tis-
sues were quickly dissected out and immediately frozen in
liquid nitrogen. For permanent storage, tissue samples
were stored at -80°C until further use. Peripheral blood
samples from mothers of the abortuses were also collected
in EDTA-Vacutainer®  blood collection tubes (Beckton-
Dickinson, USA). The study was approved by the tenets of
the Declaration of Helsinki. The informed consent was
obtained from human subjects included in this study.
Table 1: PCR primers used in PCR-SSCP analysis to identify heterozygosity in genomic DNA samples from abortuses.
Sl. No. Primer set Sequence Amplicon size
1. BWR3F 5'-AAGGCGACAGTTCTGCCGGATGA-3' 212 bp
BWR3R 5'-CAAGCCTGGGCTCACCTCTAAG-3'
2. BWR4F 5'-GCCCCACTGTGATGGACAAGCCTA-3' 259 bp
22A1LSR 5'-AGTGGGCGGCGGGACCCGTTTTG-3'
3. 22F 5'-GTACAGCGTTCCTGACAACGTTC-3' 267 p
22R 5'-GTGCTAGTGCCCTAAATCCTGCA-3'Publish with BioMed Central    and   every 
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Identification of heterozygosity in abortuses
Genomic DNA samples were extracted both from 17 abor-
tuses and their mothers' peripheral blood samples using a
DNA isolation kit from Roche Diagnostics™ (Germany)
following manufacturer's instructions. Three sets of prim-
ers were designed from exon 4 of the SLC22A1LS gene.
Primer sequences and PCR fragment sizes are given in
Table 1. These primer sequences were derived from Gen-
Bank accession number NM_007105. Genomic DNAs
from 17 abortuses were amplified separately using these
primer sets. PCR amplification was carried out in a 25 µl
volume containing 50 ng of genomic DNA, 60 ng of each
primer, 200 µmol of each dNTP, 0.25 µl αP32 dCTP (3,000
ci/mmole; NEN, USA) and 1 unit of Taq DNA polymerase
(Banglore Genei®, India) in a standard 1x buffer supplied
by the manufacturer. Amplification was performed in a
PTC100™ Programmable Thermal Controller (MJ
Research® Inc, USA) under the following conditions: an
initial denaturation at 95°C for 2 min was followed by 35
cycles at 95°C for 30 sec, 60°C for 30 sec and 72°C for 1
min with a final extension at 72°C for 5 min. PCR prod-
ucts were subjected to SSCP (Single-Stranded Conforma-
tion Polymorphism) analysis as described in Kumar et al.
[12] on a 6% non-denaturing polyacrylamide gel contain-
ing 5% glycerol. The gel was run for 16 hrs at 22°C at 4 W
using the Hoefer™ SQ3  Sequencer system (Amersham
Parmacia Biotech, USA). PCR fragment showing heterozy-
gosity in SSCP analysis was sequenced using an fmol™
DNA Cycle Sequencing kit (Promega Inc., USA) according
to manufacturer's instructions.
Allele specific expression
In order to test for the imprinted status of this gene, total
RNA samples were isolated from different tissues of abor-
tuses showing heterozygosity in SSCP analysis using a
RNeasy® Protect mini kit (Qaigen Inc., USA). First-strand
cDNAs were synthesized using a RevertAid™H First-Strand
cDNA Synthesis Kit (MBI Fermentas Inc., Canada). In
order to test for allele specific expression, cDNA samples
were subjected to SSCP analysis as described above.
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